Real-World Safety and Effectiveness of Up to 12 Months of Tralokinumab Treatment in Adults With Atopic Dermatitis Who Discontinued Dupilumab Due to Conjunctivitis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 10, n. 2, p. s729, 2026. DOI: 10.25251/1jtrf706. Disponível em: https://skin.dermsquared.com/skin/article/view/4040. Acesso em: 30 apr. 2026.